Micah R Fisher MD
Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Associate Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
1365 Clifton Rd, Building ASuite A3229Atlanta, GA 30322
Phone+1 404-778-3261
Fax+1 404-778-4431
Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1999
Certifications & Licensure
GA State Medical License 2005 - 2027
MD State Medical License 2003 - 2006
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Clinical Data Warehouse Meaningful Use, Emory Healthcare, 2013, 2016-2017
- CMS Meaningful Use Stage 1 Certification Clinical Data Warehouse Meaningful Use, Emory Healthcare, 2013, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, IQHealth, HealthSentry and P2 Sentinel, Cerner Corporation, 2013, 2016-2017
Clinical Trials
- Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI) Start of enrollment: 2009 Jan 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Publications & Presentations
PubMed
- 2 citationsBREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.Sandeep Sahay, Harold Palevsky, Karim El-Kersh, Ricardo Restrepo-Jaramillo, Abubakr A Bajwa
Respiratory Medicine. 2025-11-01 - 3 citationsEvaluation of right ventricular strain in two separate cohorts with precapillary pulmonary hypertension.Lauren M Crossman, Priyanka Rajaram, Charles Michael Hart, Maria A Pernetz, Anurag Sahu
Pulmonary Circulation. 2023-01-01 - 25 citationsBREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hyperten...Leslie A Spikes, Abubakr A Bajwa, Charles D Burger, Sapna V Desai, Michael S Eggert
Pulmonary Circulation. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
